CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
20.61
+0.06 (0.29%)
Dec 20, 2024, 4:00 PM EST - Market closed
CareDx Revenue
CareDx had revenue of $82.88M in the quarter ending September 30, 2024, with 23.35% growth. This brings the company's revenue in the last twelve months to $312.78M, up 5.26% year-over-year. In the year 2023, CareDx had annual revenue of $280.32M, down -12.89%.
Revenue (ttm)
$312.78M
Revenue Growth
+5.26%
P/S Ratio
3.46
Revenue / Employee
$486,431
Employees
643
Market Cap
1.11B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 280.32M | -41.47M | -12.89% |
Dec 31, 2022 | 321.79M | 25.40M | 8.57% |
Dec 31, 2021 | 296.40M | 104.20M | 54.22% |
Dec 31, 2020 | 192.19M | 65.13M | 51.25% |
Dec 31, 2019 | 127.07M | 50.50M | 65.95% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tilray Brands | 812.04M |
Innoviva | 352.75M |
Establishment Labs Holdings | 153.07M |
Syndax Pharmaceuticals | 16.00M |
ARS Pharmaceuticals | 2.57M |
CDNA News
- 3 days ago - CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
- 10 days ago - TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy - PRNewsWire
- 10 days ago - CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy - Business Wire
- 5 weeks ago - CareDx to Participate in Upcoming Investor Conferences - Business Wire
- 6 weeks ago - CareDx, Inc (CDNA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance - Business Wire
- 2 months ago - CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA - Accesswire
- 2 months ago - CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology - Business Wire